ByteDance completed a $369 million fundraising for its AI drug unit Anew Labs after its spin-off, The Straits Times reports, citing sources. The outlet says the raise values Anew Labs at US$1.5 billion and is intended to advance AI-driven drug discovery and development.
28.2K
2 posts, first seen 4h ago
The Straits Times reports that Anew Labs reached a US$1.5 billion valuation, with the funding aimed at AI-driven drug discovery and development.
ByteDance completed a $369 million fundraising for its AI drug unit Anew Labs after its spin-off, The Straits Times reports, citing sources. The outlet says the raise values Anew Labs at US$1.5 billion and is intended to advance AI-driven drug discovery and development.
Not enough discussion yet.
No sentiment analysis available yet.
Not enough discussion yet.
No sentiment analysis available yet.
—
Not ranked yet
—
Not ranked yet